Press Releases

2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000

2007 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 11	QLT Appoints Goldman, Sachs & Co. as Financial Advisor in Review of Strategic Options to Enhance Shareholder Value	PDF version
November 28	QLT Board Authorizes Exploration of Strategic Alternatives to Enhance Near- to Mid-Term shareholder Value	PDF version
October 25	QLT Announces Q3 Results and Provides Guidance Update	PDF version
October 18	QLT Completes Acquisition of Forsight Newco II, Inc.	PDF version
October 18	QLT Announces Visudyne® Sales for Third Quarter and Provides Visudyne Sales Guidance for 2007	PDF version
October 9	QLT Acquires Leading Edge Ocular Drug Delivery System From ForSight Labs	PDF version
August 31	Eligard® Six-Month Formulation Successfully Completes European Approval Procedure	PDF version
July 26	QLT Announces Q2 Results for 2007	PDF version
July 23	QLT Announces FDA Filing and Review of Aczone™ Labeling Supplement for Removal of Blood Screening Requirement	PDF version
July 17	QLT announces Visudyne Sales for the Second Quarter 2007	PDF version
July 10	QLT Announces District Court Decision on Trial of Massachusetts Eye and Ear Infirmary Litigation	PDF version
June 7	QLT Announces TSX Approval of US$50 Million Share Repurchase Program	PDF version
June 4	QLT Announces US$50 Million Share Repurchase Program	PDF version
May 29	QLT USA, Inc. Files Aczone™ Labeling Supplement for Removal of Blood Screening Requirement	PDF version
May 17	QLT's Shareholders Elect Philip Livingston to the Board of Directors	PDF version
April 30	QLT Strengthens its Expertise in Ocular by Adding David A. Saperstein M.D. as Interim Chief Medical Officer and Paul L. Kaufman M.D. as Head of the Ocular Scientific Advisory Board	PDF version
April 25	QLT Announces that CHMP will Recommend to the European Commission that Occult Indication be Deleted from the Visudyne® Label in European Union	PDF version
April 24	QLT announces Q1 Results for 2007	PDF version
April 23	QLT Announces First Quarter 2007 Visuydne® Sales	PDF version
March 5	QLT Settles MEEI Lawsuit with Respect to the '303 Patent	PDF version
February 22	QLT Announces 2006 Results	PDF version
February 9	QLT USA Signs Agreement with TAP to Settle United States Patent Litigation	PDF version
January 18	QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2006	PDF version
January 3	QLT USA Receives Final Payment for Generic Dermatologyand Manufacturing Business	PDF version

Visudyne® is a registered trademark of Novartis AG

Vancouver Web Design by Graphically Speaking